DNA Marker Found for Pyrethroid Resistance in Malaria Mosquitoes | News-Medical.net
- A newly identified DNA marker offers a potential breakthrough in the fight against malaria, according to research published in Science Translational Medicine on February 4, 2026.
- This discovery is particularly significant given the slowing progress in malaria control over the past decade.
- Bed nets and indoor residual spraying have long been cornerstones of malaria prevention strategies.
A newly identified DNA marker offers a potential breakthrough in the fight against malaria, according to research published in Science Translational Medicine on . The marker, found in a gene encoding a cytochrome P450 enzyme, helps Anopheles gambiae mosquitoes – a primary carrier of malaria in West and Central Africa – break down and develop resistance to pyrethroids, the insecticides used to treat bed nets.
This discovery is particularly significant given the slowing progress in malaria control over the past decade. The increasing resistance of mosquitoes to insecticides, specifically through metabolic resistance processes involving detoxification enzymes, poses a growing threat to public health. Approximately 90% of global malaria cases are reported in sub-Saharan Africa, making this research crucial for the region.
Understanding Pyrethroid Resistance
Bed nets and indoor residual spraying have long been cornerstones of malaria prevention strategies. Pyrethroids work by disrupting the nervous systems of mosquitoes, leading to paralysis and death. However, mosquitoes are evolving, and some populations are developing the ability to withstand exposure to these insecticides. This resistance isn’t always straightforward; it can manifest in various ways.
While previous studies have identified genetic markers associated with some forms of insecticide resistance, pinpointing the specific DNA-based mechanisms driving metabolic resistance – where mosquitoes break down the insecticide before it can take effect – has been a significant challenge. This new research marks the first successful identification of a DNA marker specifically linked to metabolic pyrethroid resistance in Anopheles gambiae populations in West and Central Africa.
The Role of CYP6P3 and the E205D Mutation
The research centers on the CYP6P3 gene, which encodes a cytochrome P450 enzyme. These enzymes play a critical role in detoxification processes within the mosquito. The study identified a specific mutation within this gene, designated E205D, that enhances the mosquito’s ability to metabolize and resist pyrethroids. The E205D mutation, located within a P450 enzyme cluster, effectively boosts the mosquito’s capacity to break down the insecticide.
A New Diagnostic Tool for Resistance Management
The identification of this DNA marker isn’t just a scientific curiosity; it has practical implications for malaria control efforts. Researchers have developed a reliable diagnostic test based on this marker. This test will allow public health officials to:
- Detect and monitor the spread of pyrethroid resistance in mosquito populations.
- Assess potential cross-resistance to new insecticides, helping to predict whether alternative insecticides will also become ineffective over time.
- Inform the selection of appropriate bed nets based on the genetic makeup of the local mosquito populations.
“Our study designed field-applicable tools to easily track the spread of metabolic resistance in the major malaria mosquito species and assess its impact on control interventions,” explained Professor Charles Wondji of the Liverpool School of Tropical Medicine, lead author of the study. “These important findings can help to maintain the effectiveness of insecticide-based tools such as bed nets which remain a cornerstone of malaria prevention.”
Global Impact and Future Directions
The global threat of insecticide resistance is substantial, with an estimated 200 million malaria cases and 600,000 deaths occurring annually worldwide. Addressing this challenge is crucial for improving the effectiveness of both current and future vector control strategies and reducing the overall burden of malaria.
The research, a collaborative effort between the Liverpool School of Tropical Medicine and the Centre for Research in Infectious Diseases (CRID) in Cameroon, represents a significant step forward in understanding the complex interplay between mosquitoes, insecticides, and disease transmission. By providing a tool to monitor and manage insecticide resistance, this discovery offers renewed hope in the ongoing fight against malaria.
Further research will be needed to fully understand the implications of the E205D mutation and to develop strategies to overcome pyrethroid resistance. However, this new DNA marker provides a valuable target for intervention and a crucial piece of the puzzle in the quest to eliminate malaria.